CO22 Adjusting Survival Data for Treatment Crossover in the ELEVATE-TN Trial By Using a Historical Cohort of Patients Treated with Chemoimmunotherapy in Front-Line Chronic Lymphocytic Leukemia
- Resource Type
- Abstract
- Source
- In
Value in Health July 2022 25(7) Supplement:S308-S308 - Subject
- Language
- ISSN
- 1098-3015